UPDATE 1-Shire's new dry eye drug disappoints in pivotal trial
December 06, 2013 at 03:34 AM EST
LONDON, Dec 6 (Reuters) - British drugmaker Shire, whose shares have stormed ahead this year, disappointed investors on Friday with clinical trial results of a new dry eye drug that left the product's future unclear.
